Abstract:Introduction Sickle cell disease (SCD) is the most common genetic disorder among children. As the most common type of SCD, sickle cell anemia (SCA) is associated with severe complications across the lifespan. As parents/caregivers hold primary disease management responsibility during childhood, their involvement in disease management activities, including medical decision‐making, is critical to successful and timely management of pediatric SCD. However, the processes through which caregivers make SCD‐related decisions remain unknown. The current paper examined caregivers' decision‐making processes and priorities when managing their child's SCD. Methods Parents and primary caregivers (N = 27) of children with SCA (ages 0–12) completed individual semi‐structured qualitative interviews exploring links between caregivers' decision‐making and both daily and ongoing SCA management practices. Data were transcribed verbatim, cleaned, systematically coded, and analyzed using applied thematic analysis. Results Participating caregivers were primarily Black or African American (88.9%), mothers (81.5%), publicly insured (55.6%), and single (51.9%). Caregivers described medical decision‐making across acute symptom response, preventive disease management, and treatment initiation and/or discontinuation. Across these contexts of disease management, caregivers overarchingly prioritized protecting and improving their child's quality of life. Caregivers' medical decision‐making processes were influenced by their SCA management experience, acquisition of SCA knowledge, and trust in medical providers. The extent to which these influences impacted caregivers' decision‐making varied based on disease severity, disease management experience, and time since diagnosis. Discussion Findings highlight how processes underlying caregivers' decision‐making are directly influenced and informed by caregivers' lived experiences. Future work should develop provider‐initiated collaborative interventions to support medical decision‐making.

Family reflections: sickle cell: the genetic intruder shaping our family's destiny

Family reflections: bone marrow transplant offers new lease of life for some living with sickle cell disease

Fostering a healthier generation of children with sickle cell disease through advancements in care

Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment

Curative Therapies for Sickle Cell Disease

Sickle Cell Disease: From Genetics to Curative Approaches

Treating Sickle Cell Disease: Gene Therapy Approaches

Characterizing medical decision‐making in sickle cell disease during childhood: Qualitative perspectives of caregivers

End Organ Affection in Sickle Cell Disease

Sickle cell disease: a neglected chronic disease of increasing global health importance

Family reflections: George Elliott: a first-person commentary on pediatric aplastic anemia research

Gene therapy in sickle cell disease: Attitudes and informational needs of patients and caregivers

Family reflections: congenital diaphragmatic hernia, a mother's perspective

Patient‐reported pregnancy loss and maternal complications: Insights from the sickle cell disease implementation consortium

Advancing life: innovative approaches to enhance survival in sickle cell anemia patients

Current and Future Therapeutics for Treating Patients with Sickle Cell Disease

Current state of gene therapy in sickle cell disease

"Whatever is bad goes back to the woman": The gendered blame game of sickle cell disease in Malawi and Uganda

Microbiome in sickle cell disease: Pathophysiology and therapeutic insights

Comprehensive Care in Sickle Cell Disease

Ethical and Clinical Considerations in the Use of Hydroxyurea in Pregnant Women with Sickle Cell Disease